| Natalie Fan, PHARMD | |
|
1411 E 31st St, Oakland, CA 94602-1018 | |
| (510) 535-7654 | |
| Not Available |
| Full Name | Natalie Fan |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 1411 E 31st St, Oakland, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124390760 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 64682 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Natalie Fan, PHARMD 1411 E 31st St, Oakland, CA 94602-1018 Ph: () - | Natalie Fan, PHARMD 1411 E 31st St, Oakland, CA 94602-1018 Ph: (510) 535-7654 |
News Archive
The U.S. Food and Drug Administration has issued a draft guidance on the use of inks, pigments, flavors, and other physical-chemical identifiers (PCIDs) by manufacturers to make drug products more difficult to duplicate by counterfeiters, and to make it easier to identify the genuine version of the drug.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
Sunrise Senior Living, Inc. announced today that the Company and certain of its affiliates have entered into purchase and sale agreements with Ventas, Inc. and certain of its affiliates to sell to Ventas all of Sunrise's joint venture interests in nine limited liability companies in the U.S. and two limited partnerships in Canada, which collectively own 58 communities managed by Sunrise.
The Lancet Oncology has published results from the largest ever trial of a single melanoma treatment. The open label safety study was conducted to assess the tolerability of Zelboraf (vemurafenib), and featured 3,222 patients from across 44 countries.1 246 of these patients were from the UK.
As Hurricane Ivan pummels the U.S. Gulf Coast, Saint Louis University continues to study what we need to do to ensure Grandma's safety in case of a disaster.
› Verified 6 days ago
Dr. Gachiru L Kamau-devers, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3550 Fruitvale Ave, Oakland, CA 94602 Phone: 510-336-9305 Fax: 510-336-3925 | |
Jessica Chang, PHARM.D., APH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-8859 | |
Trong-nghia Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3320 Fruitvale Ave, Oakland, CA 94602 Phone: 510-530-3156 Fax: 510-530-1082 | |
Jocelyn Chan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 Harrison St Fl 13, Oakland, CA 94612 Phone: 510-625-2139 | |
Norma Miyeko Marubayashi Holloway, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-6468 | |
Mrs. Michele Ng, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-6141 | |
Carol K Lam, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 Harrison St Ste 1301, Oakland, CA 94612 Phone: 626-941-4706 |